REZOLUTE INC. - COMMON STOCK (NV)

Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)

13 12 2023 08:00:00 提供 Nasdaq GlobeNewswire

Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology Day

17 11 2023 08:00:00 提供 Nasdaq GlobeNewswire

Rezolute Reports First Quarter Fiscal 2024 Results

13 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for Enhanced Regulatory Support of RZ358 in Congenital Hyperinsulinism

17 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

Rezolute Announces Further Evidence of RZ358’s Efficacy in Tumor-Mediated Hyperinsulinism

11 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

Rezolute Reports Full Year Fiscal 2023 Results and Highlights Company Progress

14 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences in September

06 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

Rezolute to Initiate a Pivotal Phase 3 Study of RZ358 in Participants 3 Months of Age and Older with Congenital Hyperinsulinism

27 6 2023 16:05:00 提供 Nasdaq GlobeNewswire

Rezolute Reports Third Quarter Fiscal 2023 Results and Highlights Company Progress

11 5 2023 16:05:01 提供 Nasdaq GlobeNewswire

Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema

23 3 2023 16:50:08 提供 Nasdaq GlobeNewswire

Rezolute to Highlight RZ402 Phase 2 Clinical Program with Leading Clinical Expert

08 3 2023 07:00:02 提供 Nasdaq GlobeNewswire

Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress

10 2 2023 16:05:00 提供 Nasdaq GlobeNewswire

Rezolute Announces Initiation of a Phase 2 Study of RZ402 in Patients with Diabetic Macular Edema

15 12 2022 07:00:00 提供 Nasdaq GlobeNewswire

Rezolute Reports First Quarter Fiscal 2023 Results and Highlights Company Progress

09 11 2022 16:05:02 提供 Nasdaq GlobeNewswire

Rezolute to Present at the Jefferies London Healthcare Conference

01 11 2022 07:00:01 提供 Nasdaq GlobeNewswire

Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting

20 10 2022 07:00:01 提供 Nasdaq GlobeNewswire

Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress

15 9 2022 16:05:00 提供 Nasdaq GlobeNewswire

Rezolute Announces Presentation at the 60th Annual ESPE Meeting

07 9 2022 07:00:01 提供 Nasdaq GlobeNewswire

Rezolute Announces Promotion of Brian Roberts, M.D. to Chief Medical Officer

01 6 2022 07:00:01 提供 Nasdaq GlobeNewswire

Rezolute Reports Third Quarter Fiscal 2022 Financial Results and Highlights Company Progress

12 5 2022 16:05:01 提供 Nasdaq GlobeNewswire